The Symposium will focus broadly on emerging technology and therapies to include all phases of the innovation process, (e.g., ongoing or recently completed studies on devices, ablation, and mapping). The program addresses hot topics on basic, pediatric and adult electrophysiology, including multidisciplinary approaches in treatment of AF, HF, and prevention of SCD. Courses on CRT, AF ablation and ECG workshop are included in the program. The program, abstracts and registration information are available on the Symposium website .
A new study shows that atrial fibrillation (AF) increases the risk of dementia in older adults who have not had a stroke and have normal baseline cognitive function. The meta-analysis, published in the November edition of HeartRhythm,the official journal of the Heart Rhythm Society, is the first-of-its-kind to observe a large population of patients over a relatively long follow-up period. The study results support an independent longitudinal relationship between the two conditions, therefore associating the presence of AF with greater risk of developing dementia.
Late-Breaking Clinical Trials will be revealed at Heart Rhythm 2015, the Heart Rhythm Society’s 36th Annual Scientific Sessions.
The first patient tests of a new leadless pacemaker show that the device can deliver the same life-saving therapy as a traditional single-chamber pacemaker without potential lead-related complications. The findings are part of the LEADLESS trial and were released today at Heart Rhythm 2013, the Heart Rhythm Society’s 34th Annual Scientific Sessions.
A new Canadian study shows that operating without interrupting warfarin treatment at the time of cardiac device surgery is safe and markedly reduces the incidence of clinically significant hematomas compared to the current standard of care. The new findings were released today at Heart Rhythm 2013,the Heart Rhythm Society’s 34th Annual Scientific Sessions.
Pedirhythm 5: Pediatric and Congenital Rhythm Congress
The Heart Rhythm Society (HRS), the European Heart Rhythm Association (EHRA) and Asia Pacific Heart Rhythm Society (APHRS), release the HRS/EHRA/APHRS Expert Consensus Statement on the Diagnosis and Management of Patients with Inherited Primary Arrhythmia Syndromes. The expert consensus statement presented today at Heart Rhythm 2013, the Heart Rhythm Society’s 34th Annual Scientific Sessions, provides the first comprehensive statement of recommendations on the proper diagnosis and management of patients with inherited primary arrhythmia syndromes.
Prominent experts debate which of two treatments, cryoballoon or RF ablation, is the superior treatment for paroxysmal atrial fibrillation